Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

July 1, 1982; Volume 129,Issue 1

COMMUNICATIONS

  • You have accessRestricted access
    Antibodies to alpha-interferon in a patient with systemic lupus erythematosus.
    S Panem, I J Check, D Henriksen and J Vilcek
    J Immunol July 1, 1982, 129 (1) 1-3;
  • You have accessRestricted access
    Expression of B-L (Ia-like) antigens on macrophages from chicken lymphoid organs.
    R Peck, K K Murthy and O Vainio
    J Immunol July 1, 1982, 129 (1) 4-5;

ARTICLES

  • You have accessRestricted access
    T cell-independent responses to an Ir gene-controlled antigen. I. Characteristics of the immune response to insulin complexed to Brucella abortus.
    J W Thomas, R P Bucy and J A Kapp
    J Immunol July 1, 1982, 129 (1) 6-10;
  • You have accessRestricted access
    Cytokine-dependent thymocyte responses. II. Generation of cytotoxic T lymphocytes from immature thymocytes.
    P J Conlon, C A Ramthun, C S Henney and S Gillis
    J Immunol July 1, 1982, 129 (1) 11-17;
  • You have accessRestricted access
    The functional capacity of thymus subpopulations: limit-dilution analysis of all precursors of cytotoxic lymphocytes and of all T cells capable of proliferation in subpopulations separated by the use of peanut agglutinin.
    C Wei-Feng, R Scollay and K Shortman
    J Immunol July 1, 1982, 129 (1) 18-24;
  • You have accessRestricted access
    Local passive transfer of delayed-type hypersensitivity in the mouse.
    H Scovern and F S Kantor
    J Immunol July 1, 1982, 129 (1) 25-29;
  • You have accessRestricted access
    A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.
    J W Schrader and I Clark-Lewis
    J Immunol July 1, 1982, 129 (1) 30-35;
  • You have accessRestricted access
    The immune response in aged C57BL/6 mice. II. Characterization and reversal of a defect in the ability of aged spleen cells to respond to the adjuvant properties of Fc fragments.
    E L Morgan and W O Weigle
    J Immunol July 1, 1982, 129 (1) 36-39;
  • You have accessRestricted access
    Differentiation and activation of nu/nu splenic T cell precursors by mature peripheral T cells in the absence of thymus.
    J S Lipsick, L Serunian, V L Sato and N O Kaplan
    J Immunol July 1, 1982, 129 (1) 40-45;
  • You have accessRestricted access
    A human helper T cell clone secreting both killer helper factor(s) and T cell-replacing factor(s).
    T Kaieda, M Okada, N Yoshimura, S Kishimoto, Y Yamamura and T Kishimoto
    J Immunol July 1, 1982, 129 (1) 46-51;
  • You have accessRestricted access
    Alkaline phosphatase activity as a membrane marker for activated B cells.
    C García-Rozas, A Plaza, F Díaz-Espada, M Kreisler and C Martínez-Alonso
    J Immunol July 1, 1982, 129 (1) 52-55;
  • You have accessRestricted access
    Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    M R Duncan, F W George 4th and J W Hadden
    J Immunol July 1, 1982, 129 (1) 56-62;
  • You have accessRestricted access
    Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
    G Moser, S J Burakoff and A K Abbas
    J Immunol July 1, 1982, 129 (1) 63-69;
  • You have accessRestricted access
    Potentiation of the primary humoral immune response in vitro by C5a anaphylatoxin.
    M G Goodman, D E Chenoweth and W O Weigle
    J Immunol July 1, 1982, 129 (1) 70-75;
  • You have accessRestricted access
    Gamma interferon (IFN gamma) and IFN alpha/beta suppress murine myeloid colony formation (CFU-C)N: magnitude of suppression is dependent upon level of colony-stimulating factor (CSF).
    G R Klimpel, W R Fleischmann Jr and K D Klimpel
    J Immunol July 1, 1982, 129 (1) 76-80;
  • You have accessRestricted access
    Detection of a common antigen on murine B cells and Lyt-2+ T cells by a rat monoclonal antibody, 14D10.
    J T Kung, S O Sharrow, M G Mage and W E Paul
    J Immunol July 1, 1982, 129 (1) 81-86;
  • You have accessRestricted access
    An epidermal cell-derived cytokine triggers the in vivo synthesis of serum amyloid A by hepatocytes.
    M B Sztein, T A Luger and J J Oppenheim
    J Immunol July 1, 1982, 129 (1) 87-90;
  • You have accessRestricted access
    Phorbol ester tumor promoter modulation of alloantigen-specific T lymphocyte responses.
    P E Andreotti
    J Immunol July 1, 1982, 129 (1) 91-96;
  • You have accessRestricted access
    Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation.
    R J Falkoff, L P Zhu and A S Fauci
    J Immunol July 1, 1982, 129 (1) 97-102;
  • You have accessRestricted access
    Ia-positive cells generated by PWM-stimulation within OKT4+ subset interact with OKT8+ cells for inducing active suppression on B cell differentiation in vitro.
    A Yachie, T Miyawaki, T Yokoi, T Nagaoki and N Taniguchi
    J Immunol July 1, 1982, 129 (1) 103-106;
  • You have accessRestricted access
    Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis.
    D J Volkman, S P Allyn and A S Fauci
    J Immunol July 1, 1982, 129 (1) 107-112;
  • You have accessRestricted access
    The regulation of Ig synthesis after marrow transplantation. IV. T4 and T8 subset function in patients with chronic graft-vs-host disease.
    L G Lum, N Orcutt-Thordarson, M C Seigneuret and R Storb
    J Immunol July 1, 1982, 129 (1) 113-119;
  • You have accessRestricted access
    Two isoallergens of short ragweed component Ra5.
    M Roebber, D G Klapper and D G Marsh
    J Immunol July 1, 1982, 129 (1) 120-125;
  • You have accessRestricted access
    Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells.
    M Hansson, M Beran, B Andersson and R Kiessling
    J Immunol July 1, 1982, 129 (1) 126-132;
  • You have accessRestricted access
    Serum IgM-bound secretory component (sIgM) in liver diseases: comparative molecular state of the secretory component in serum and bile.
    D L Delacroix, P Jonard, C Dive and J P Vaerman
    J Immunol July 1, 1982, 129 (1) 133-138;
  • You have accessRestricted access
    Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
    R S Geha
    J Immunol July 1, 1982, 129 (1) 139-144;
  • You have accessRestricted access
    Differential interference by azathioprine and 6-mercaptopurine with antibody-mediated immunoregulation: synergism of azathioprine and antibody in the control of an immune response.
    J L Medzihradsky, C Klein and G B Elion
    J Immunol July 1, 1982, 129 (1) 145-149;
  • You have accessRestricted access
    Selective suppression of human B lymphocyte differentiation into IgG-producing cells by soluble Fc gamma receptors.
    L T Bich-Thuy and J P Revillard
    J Immunol July 1, 1982, 129 (1) 150-152;
  • You have accessRestricted access
    Specific in vitro antibody responses by human blood lymphocytes: apparent nonresponsiveness of PBL is due to a lack of recirculating memory B cells.
    R E Callard, G W McCaughan, J Babbage and R L Souhami
    J Immunol July 1, 1982, 129 (1) 153-156;
  • You have accessRestricted access
    Purification and partial characterization of a C1q inhibitor from the membranes of human peripheral blood lymphocytes.
    B Ghebrehiwet and M Hamburger
    J Immunol July 1, 1982, 129 (1) 157-162;
  • You have accessRestricted access
    Purification and characterization of a protein with fibronectin determinants and phagocytosis-enhancing activity.
    J K Czop, J L Kadish and K F Austen
    J Immunol July 1, 1982, 129 (1) 163-167;
  • You have accessRestricted access
    Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    P C Giclas
    J Immunol July 1, 1982, 129 (1) 168-172;
  • You have accessRestricted access
    Splenic regulation of the immune response in Syrian hamsters.
    F J Waxman and J E Coe
    J Immunol July 1, 1982, 129 (1) 173-179;
  • You have accessRestricted access
    Functional and developmental differences between genetically controlled phenotypes of the sixth component of complement in rabbits.
    M B Goldman, C Cohen, K S O'Rourke and J N Goldman
    J Immunol July 1, 1982, 129 (1) 180-183;
  • You have accessRestricted access
    Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
    A Nicholson-Weller, J Burge, D T Fearon, P F Weller and K F Austen
    J Immunol July 1, 1982, 129 (1) 184-189;
  • You have accessRestricted access
    The modification of human immunoglobulin binding to staphylococcal protein A using diethylpyrocarbonate.
    D A Haake, E C Franklin and B Frangione
    J Immunol July 1, 1982, 129 (1) 190-192;
  • You have accessRestricted access
    VH families in the antibody response to p-azophenylarsonate: correlation between serology and amino acid sequence.
    E C Milner and J D Capra
    J Immunol July 1, 1982, 129 (1) 193-199;
  • You have accessRestricted access
    Histamine suppresses in vitro synthesis of precursor (pro-C5) of the fifth complement component (C5) by mouse peritoneal macrophages.
    Y M Ooi
    J Immunol July 1, 1982, 129 (1) 200-205;
  • You have accessRestricted access
    Antigenic structure of sperm whale myoglobin. I. Partition of specificities between antibodies reactive with peptides and native protein.
    G Lando, J A Berzofsky and M Reichlin
    J Immunol July 1, 1982, 129 (1) 206-211;
  • You have accessRestricted access
    Antigenic structure of sperm whale myoglobin. II. Characterization of antibodies preferentially reactive with peptides arising in response to immunization with the native protein.
    G Lando and M Reichlin
    J Immunol July 1, 1982, 129 (1) 212-216;
  • You have accessRestricted access
    Functional analysis of GAT-specific T cell clones: H-2-restricted monoclonal T helper cells do not regulate expression of antibody isotypes.
    M Seman, V Zilberfarb, M L Gougeon and J Theze
    J Immunol July 1, 1982, 129 (1) 217-221;
  • You have accessRestricted access
    Characterization of H-2Db antigens implies haplotype differences in the number of H-2 molecules expressed.
    M R Melino, E A Nichols, H R Strausser and T H Hansen
    J Immunol July 1, 1982, 129 (1) 222-226;
  • You have accessRestricted access
    Two loci in I-J subregion of the H-2 complex controlling molecules selectively expressed on suppressor and helper T cells.
    A Ochi, M Nonaka, K Hayakawa, K Okumura and T Tada
    J Immunol July 1, 1982, 129 (1) 227-231;
  • You have accessRestricted access
    The induction of alloreactive cytotoxic responses in vivo are inhibited by pretreatment with M is-disparate cells.
    R L Hayes and H N Claman
    J Immunol July 1, 1982, 129 (1) 232-235;
  • You have accessRestricted access
    A high frequency idiotypic marker of anti-DNA autoantibodies in MRL-Ipr/Ipr mice.
    J Rauch, E Murphy, J B Roths, B D Stollar and R S Schwartz
    J Immunol July 1, 1982, 129 (1) 236-241;
  • You have accessRestricted access
    Map position of Igh-Oxa gene within the Igh region of the DBA/2 mouse strain.
    J Pelkonen, K Karjalainen, O Mäkelä and B A Taylor
    J Immunol July 1, 1982, 129 (1) 242-244;
  • You have accessRestricted access
    Detection of an altered I-A beta polypeptide in the murine Ir mutant, B6.C-h-2bm12.
    D R Lee, T H Hansen and S E Cullen
    J Immunol July 1, 1982, 129 (1) 245-251;
  • You have accessRestricted access
    Restoration of allograft responsiveness in B rats by interleukin 2 and/or adherent cells.
    A E Clason, A J Duarte, J W Kupiec-Weglinski, J N Williams, B S Wang, T B Strom and N L Tilney
    J Immunol July 1, 1982, 129 (1) 252-259;
  • You have accessRestricted access
    Arrangement of lambda light chain genes in mutant clones of the MOPC 315 mouse myeloma cells.
    N Hozumi, G Wu, H Murialdo, R Baumal, T Mosmann, L Winberry and A Marks
    J Immunol July 1, 1982, 129 (1) 260-266;
  • You have accessRestricted access
    Role of the major histocompatibility complex in T cell activation of B cell subpopulations: antigen-specific and H-2-restricted monoclonal TH cells activate Lyb-5+ B cells through an antigen-nonspecific and H-2-unrestricted effector pathway.
    R J Hodes, M Shigeta, K S Hathcock, C G Fathman and A Singer
    J Immunol July 1, 1982, 129 (1) 267-271;
  • You have accessRestricted access
    Genetics of cell interactions in aged mice: age-related decline in capacity of parental cells or environment to induce allogeneic effects on F1 lymphocytes.
    R I Zuberi and D H Katz
    J Immunol July 1, 1982, 129 (1) 272-277;
  • You have accessRestricted access
    Coexistence of defective and normal immunologic functions in lymphocytes and macrophages from osteopetrotic (op) rats.
    N Hochman, L M Wahl and A L Sandberg
    J Immunol July 1, 1982, 129 (1) 278-281;
  • You have accessRestricted access
    Inhibition of monocyte-mediated antibody-dependent cellular cytotoxicity by ouabain: relationship between cytotoxic function, glycolysis, and intracellular cation homeostasis.
    S Ladisch and S A Feig
    J Immunol July 1, 1982, 129 (1) 282-286;
  • You have accessRestricted access
    Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides.
    P Katz, A M Zaytoun and A S Fauci
    J Immunol July 1, 1982, 129 (1) 287-296;
  • You have accessRestricted access
    Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP.
    P Katz, J C Roder, A M Zaytoun, R B Herberman and A S Fauci
    J Immunol July 1, 1982, 129 (1) 297-302;
  • You have accessRestricted access
    Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells.
    A Ben-Nun and I R Cohen
    J Immunol July 1, 1982, 129 (1) 303-308;
  • You have accessRestricted access
    Immune complex induced generation of oxygen metabolites by human neutrophils.
    S J Weiss and P A Ward
    J Immunol July 1, 1982, 129 (1) 309-313;
  • You have accessRestricted access
    Mouse mast cell activation and desensitization for immune aggregate-induced histamine release.
    P C Fox, L K Basciano and R P Siraganian
    J Immunol July 1, 1982, 129 (1) 314-319;
  • You have accessRestricted access
    Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
    D R Milich and F V Chisari
    J Immunol July 1, 1982, 129 (1) 320-325;
  • You have accessRestricted access
    Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    J F Sheridan, A D Donnenberg, L Aurelian and D J Elpern
    J Immunol July 1, 1982, 129 (1) 326-331;
  • You have accessRestricted access
    Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
    P C Leijh, M T van den Barselaar, M R Daha and R van Furth
    J Immunol July 1, 1982, 129 (1) 332-337;
  • You have accessRestricted access
    Identification and characterization of excretory-secretory products of Brugia malayi, adult filarial parasites.
    N A Kaushal, R Hussain, T E Nash and E A Ottesen
    J Immunol July 1, 1982, 129 (1) 338-343;
  • You have accessRestricted access
    Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
    H W Murray, H Masur and J S Keithly
    J Immunol July 1, 1982, 129 (1) 344-350;
  • You have accessRestricted access
    Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes.
    H W Murray
    J Immunol July 1, 1982, 129 (1) 351-357;
  • You have accessRestricted access
    Use of H-2:H-7 congenic mice to study H-2-mediated resistance to Friend leukemia virus.
    P J Wettstein and K J Blank
    J Immunol July 1, 1982, 129 (1) 358-361;
  • You have accessRestricted access
    Augmentation of delayed-type hypersensitivity to serum proteins by vesicular stomatitis virus infection in mice: virus-suppressor cell interactions.
    Y Katsura, Y Takaoki and N Minato
    J Immunol July 1, 1982, 129 (1) 362-365;
  • You have accessRestricted access
    Demonstration that nonspecific bovine Brucella abortus agglutinin is EDTA-labile and not calcium-dependent.
    K Nielsen and J R Duncan
    J Immunol July 1, 1982, 129 (1) 366-369;
  • You have accessRestricted access
    Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    S Kohl and L S Loo
    J Immunol July 1, 1982, 129 (1) 370-376;
  • You have accessRestricted access
    T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii.
    A N Jayawardena, D B Murphy, C A Janeway and R K Gershon
    J Immunol July 1, 1982, 129 (1) 377-381;
  • You have accessRestricted access
    Repeated isolation of unique Qa2+ Ia+ clonally derived cell lines from Qa2- mice.
    R S Rosenson, L Flaherty, H Levine and C L Reinisch
    J Immunol July 1, 1982, 129 (1) 382-387;
  • You have accessRestricted access
    Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities.
    K Kumagai, K Itoh, R Suzuki, S Hinuma and F Saitoh
    J Immunol July 1, 1982, 129 (1) 388-394;
  • You have accessRestricted access
    Studies of murine large granular lymphocytes. II. Tissue, strain, and age distributions of LGL and LAL.
    K Itoh, R Suzuki, Y Umezu, K Hanaumi and K Kumagai
    J Immunol July 1, 1982, 129 (1) 395-405;
  • You have accessRestricted access
    Structural characterization of the human T cell surface antigen (p67) isolated from normal and neoplastic lymphocytes.
    R I Fox, D Harlow, I Royston and J Elder
    J Immunol July 1, 1982, 129 (1) 401-405;
  • You have accessRestricted access
    A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    J W Pickering and F B Gelder
    J Immunol July 1, 1982, 129 (1) 406-412;
  • You have accessRestricted access
    The effect of target cell differentiation on human natural killer cell activity: a specific defect in target cell binding and early activation events.
    J A Werkmeister, S L Helfand, T Haliotis, H F Pross and J C Roder
    J Immunol July 1, 1982, 129 (1) 413-418;
  • You have accessRestricted access
    Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia.
    H C Rümke, F Miedema, I J ten Berge, F Terpstra, H J van der Reijden, R J van de Griend, H G de Bruin, A E von dem Borne, J W Smit, W P Zeijlemaker and C J Melief
    J Immunol July 1, 1982, 129 (1) 419-426;
  • You have accessRestricted access
    Distinct signals for antibody-dependent and nonspecific killing of tumor targets mediated by macrophages.
    P Ralph, N Williams, I Nakoinz, H Jackson and J D Watson
    J Immunol July 1, 1982, 129 (1) 427-432;
  • You have accessRestricted access
    Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
    S C Wright and B Bonavida
    J Immunol July 1, 1982, 129 (1) 433-439;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 129, Issue 1
1 Jul 1982
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • COMMUNICATIONS
  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606